Drug Shortage Report for MYLAN-BUPRENORPHINE/NALOXONE

Last updated on 2019-09-18 History
Report ID 7392
Drug Identification Number 02408090
Brand name MYLAN-BUPRENORPHINE/NALOXONE
Common or Proper name BUPRENORPHINE/NALOXONE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) BUPRENORPHINE NALOXONE
Strength(s) 2MG 0.5MG
Dosage form(s) TABLET
Route of administration SUBLINGUAL
Packaging size 100BT
ATC code N07BC
ATC description DRUGS USED IN ADDICTIVE DISORDERS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-07-03
Actual start date 2018-06-26
Estimated end date Unknown
Actual end date 2019-09-17
Shortage status Resolved
Updated date 2019-09-18
Company comments discontinued in ID 94044. Last lot 3085355 exp 2019-05-31
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v83 2018-02-02 English Compare
v82 2018-01-31 French Compare
v81 2018-01-31 English Compare
v80 2018-01-29 French Compare
v79 2018-01-29 English Compare
v78 2018-01-26 French Compare
v77 2018-01-26 English Compare
v76 2018-01-24 French Compare
v75 2018-01-24 English Compare
v74 2018-01-22 French Compare
v73 2018-01-22 English Compare
v72 2018-01-19 French Compare
v71 2018-01-19 English Compare
v70 2018-01-17 French Compare
v69 2018-01-17 English Compare
v68 2018-01-15 French Compare
v67 2018-01-15 English Compare
v66 2018-01-12 French Compare
v65 2018-01-12 English Compare
v64 2018-01-10 French Compare

Showing 61 to 80 of 143